Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bruce W. Altrock is active.

Publication


Featured researches published by Bruce W. Altrock.


Cell | 1996

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF

Shuqian Jing; Duanzhi Wen; Yanbin Yu; Paige Holst; Yi Luo; Mei Fang; Rami Tamir; Laarni Antonio; Zheng Hu; Rod Cupples; Jean-Claude Louis; Sylvia Hu; Bruce W. Altrock; Gary M. Fox

We report the expression cloning and characterization of GDNFR-alpha, a novel glycosylphosphatidylinositol-linked cell surface receptor for glial cell line-derived neurotrophic factor (GDNF). GDNFR-alpha binds GDNF specifically and mediates activation of the Ret protein-tyrosine kinase (PTK). Treatment of Neuro-2a cells expressing GDNFR-alpha with GDNF rapidly stimulates Ret autophosphorylation. Ret is also activated by treatment with a combination of GDNF and soluble GDNFR-alpha in cells lacking GDNFR-alpha, and this effect is blocked by a soluble Ret-Fc fusion protein. Ret activation by GDNF was also observed in cultured embryonic rat spinal cord motor neurons, a cell type that responds to GDNF in vivo. A model for the stepwise formation of a GDNF signal-transducing complex including GDNF, GDNFR-alpha, and the Ret PTK is proposed.


Biochemical and Biophysical Research Communications | 1988

Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli

Larry B. Tsai; Hsieng S. Lu; William C. Kenney; Craig Curless; Michael L. Klein; Por-Hsiung Lai; Dennis Fenton; Bruce W. Altrock; Michael Benjamin Mann

Interleukin-2 produced from a recombinant E. coli was found to contain as much as 19% norleucine in place of methionine in a minimal medium fermentation. Medium supplementation experiments and use of a leucine-requiring mutant host strain indicated the origin of norleucine to be de novo biosynthesis by reactions involving the enzymes of the leucine biosynthetic pathway. The misincorporation was highly suppressed by addition of either L-leucine or L-methionine to the fermentation and completely suppressed by adding both amino acids.


Journal of Cellular Biochemistry | 1991

Role of platelet‐derived growth factor in wound healing

Glenn F. Pierce; Thomas A. Mustoe; Bruce W. Altrock; Thomas F. Deuel; Arlen R. Thomason


Archive | 1992

Use of gm-csf and g-csf to promote accelerated wound healing

Glenn F. Pierce; Bruce W. Altrock


Journal of interferon research | 1986

Structure and activity of glycosylated human interferon-γ

Tsutomu Arakawa; Yeuh-Rong Hsu; David Chang; Nowell Stebbing; Bruce W. Altrock


Archive | 1994

Use of GM-CSF to promote accelerated wound healing

Glenn F. Pierce; Bruce W. Altrock


Archive | 1989

Interleukin ii analogs

Bruce W. Altrock; Thomas C. Boone; Robert A. Goldman; William C. Kenny; Yitzhak Stabinsky


Archive | 1984

Monoclonal antibodies to human immune interferon

Bruce W. Altrock


Archive | 1983

Monoclonal antibodies which specifically bind to human immune interferon

Bruce W. Altrock


Journal of interferon research | 1986

Antiviral and Antitumor Effects of a Human Interferon Analog, IFN-αCon1, Assessed in Hamsters

Bruce W. Altrock; Katherine D. Fagin; Helen R. Hockman; Eleanor N. Fish; Lawrence Goldstein; David Chang; Karen Duker; No Well Stebbing

Collaboration


Dive into the Bruce W. Altrock's collaboration.

Top Co-Authors

Avatar

David Chang

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge